The present invention describes steroid conjugates. These single drug entities are formed by connecting two or more steroids via a linker. Upon topical application to the eye, the conjugate hybrid would undergo enzymatic and/or hydrolytic cleavage to release the individual steroid drugs.
申请公布号
EP2964268(A1)
申请公布日期
2016.01.13
申请号
EP20140712952
申请日期
2014.03.06
申请人
ALLERGAN, INC.
发明人
SINHA, SANTOSH C.;CHOW, KEN;WANG, LIMING;BHAT, SMITA S.;SWIFT, BRANDON D.;ATTAR, MAYSSA;GARST, MICHAEL E.